Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
Biotech
Alveus emerges to tackle obesity drug pitfalls with $160M
Looking to improve on current obesity drugs, Alveus Therapeutics has debuted with nearly $160 million and an impressive roster of executives.
Fraiser Kansteiner
Jan 8, 2026 7:30am
Roche commits $100M to keep its GLP-1 Structure sound
Jan 6, 2026 10:21am
MetaVia weighs in with 9% loss to enter the obesity ring
Jan 5, 2026 10:44am
Altimmune eyes phase 3 MASH trial as weight loss deepens
Dec 19, 2025 8:30am
Lilly's obesity pill maintains weight lost on injectable GLP-1s
Dec 18, 2025 8:20am
How Zealand CSO aims to create a 'generational biotech leader'
Dec 12, 2025 1:00pm
